Pedalitin
98%
- Product Code: 225965
CAS:
22384-63-0
| Molecular Weight: | 316.262 g./mol | Molecular Formula: | C₁₆H₁₂O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 659.3±55.0℃ at 760 mmHg | |
| Density: | 1.6±0.1g/ml | Storage Condition: | Room temperature |
Product Description:
Pedalitin is primarily used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and analgesic agents. It exhibits inhibitory activity against certain cyclooxygenase (COX) enzymes, contributing to its role in reducing prostaglandin production, which is associated with pain and inflammation. Due to its structural properties, it is also investigated for potential use in developing treatments for neurodegenerative conditions, where modulation of oxidative stress and inflammation is beneficial. In research settings, Pedalitin serves as a reference compound for structure-activity relationship (SAR) studies aimed at optimizing drug candidates with improved bioavailability and reduced side effects.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Yellow Solid |
| Purity (%) | 97.5-100% |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿9,550.00 |
+
-
|
| 5mg | 10-20 days | ฿41,350.00 |
+
-
|
Pedalitin
Pedalitin is primarily used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and analgesic agents. It exhibits inhibitory activity against certain cyclooxygenase (COX) enzymes, contributing to its role in reducing prostaglandin production, which is associated with pain and inflammation. Due to its structural properties, it is also investigated for potential use in developing treatments for neurodegenerative conditions, where modulation of oxidative stress and inflammation is beneficial. In research settings, Pedalitin serves as a reference compound for structure-activity relationship (SAR) studies aimed at optimizing drug candidates with improved bioavailability and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :